04-Sep-2013 | research and development
Daiichi Sankyo's Once-Daily Edoxaban Shows Efficacy and Superiority for the Treatment of Symptomatic VTE
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced results from the global phase 3 Hokusai-VTE study of 8,292 patients with either acute ...